Barclays Lowers Agilon Health (NYSE:AGL) Price Target to $1.50

Agilon Health (NYSE:AGL) had its target price cut by equities research analysts at Barclays from $3.00 to $1.50 in a research note issued on Wednesday,Benzinga reports. The firm presently has an “underweight” rating on the stock. Barclays‘s target price would suggest a potential upside of 73.41% from the stock’s current price.

Several other analysts have also issued reports on the stock. The Goldman Sachs Group upped their price target on shares of Agilon Health from $2.50 to $5.00 and gave the stock a “neutral” rating in a research report on Thursday, May 8th. Benchmark decreased their price target on shares of Agilon Health from $4.00 to $1.50 and set a “buy” rating on the stock in a research note on Wednesday. Cowen reaffirmed a “hold” rating on shares of Agilon Health in a report on Tuesday, April 15th. Robert W. Baird reduced their price target on shares of Agilon Health from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 15th. Finally, Sanford C. Bernstein raised Agilon Health from a “market perform” rating to an “outperform” rating and raised their target price for the company from $3.30 to $8.50 in a report on Tuesday, April 8th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $4.07.

Agilon Health Price Performance

AGL stock opened at $0.87 on Wednesday. The stock has a market capitalization of $358.47 million, a P/E ratio of -1.12 and a beta of 0.14. Agilon Health has a fifty-two week low of $0.71 and a fifty-two week high of $6.08. The business has a 50-day moving average of $2.10 and a 200-day moving average of $3.17.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%. The business had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the prior year, the business earned ($0.07) earnings per share. Agilon Health’s revenue was down 5.9% compared to the same quarter last year. Equities analysts expect that Agilon Health will post -0.59 EPS for the current year.

Institutional Trading of Agilon Health

Several institutional investors and hedge funds have recently bought and sold shares of AGL. Connor Clark & Lunn Investment Management Ltd. lifted its position in Agilon Health by 1,028.9% during the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 789,703 shares of the company’s stock valued at $1,816,000 after buying an additional 719,751 shares during the period. Versor Investments LP purchased a new position in shares of Agilon Health in the 2nd quarter worth about $320,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Agilon Health during the 2nd quarter valued at about $68,000. Inspire Investing LLC raised its holdings in Agilon Health by 112.9% in the second quarter. Inspire Investing LLC now owns 166,741 shares of the company’s stock worth $384,000 after buying an additional 88,411 shares during the last quarter. Finally, Blair William & Co. IL lifted its stake in shares of Agilon Health by 9.4% in the second quarter. Blair William & Co. IL now owns 156,394 shares of the company’s stock worth $360,000 after buying an additional 13,411 shares in the last quarter.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.